India has launched BIRSA 101, the nation’s first indigenous CRISPR-based gene therapy for Sickle Cell Disease, marking a major leap in genomic medicine and affordable healthcare. https://english.mathrubhumi.com/lifestyle/health/india-crispr-gene-therapy-sickle-cell-disease-n4em93uz?utm_source=dlvr.it&utm_medium=mastodon #SickleCellDisease #CRISPRIndia #Birsa101 #GenomicMedicine